Noxae

DBCAT000150Pharmacologic class

Agents capable of exerting a harmful effect on the body. A DrugBank category of 174 drugs. 94 of them are approved.

Drugs: 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
2-deoxyglucose
2-Methoxyethanol
2'-Deoxyuridine
5,6-dihydro-5-azacytidine
6-diazo-5-oxo-L-norleucine
8-azaguanine
Acivicin
Adozelesin
Altretamine
Aminacrine
Ancitabine
Aniline
Arsenite ion
Azacitidine
Azathioprine
Bendamustine
Benznidazole
Bisphenol A diglycidyl ether
Bivatuzumab mertansine
Bizelesin
Botulinum toxin type A
Brentuximab vedotin
Bromoform
Broxuridine
and 149 more with a free account

What you can answer from here — as of August 24, 2016

174DrugsEach linked to its full drug card

300Drug targetsEvery drug–target pair in the class, with bond type

16,302Marketed productsAcross the regions we cover, with dosage forms and routes

37Routes of administrationHow the drugs in this class are given

Which targets do Noxae share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.